1.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068400, MSKCC-00085, MERCK-026-01, NCI-G00-1898, NCT00008359
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 months and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0991-062, 2008_013, NCT00717860
|
|
3.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-65041, EUDRACT-2004-002944-90, NCT00110045
|
|
4.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 17 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2004_100, Formerly-0404CCAI, MK0991-043, NCT00082524
|
|
5.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 2 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2004_101, Formerly-0404ETPP, MK0991-044, NCT00082537
|
|
6.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Uni-Koeln-687, EudraCT- No.: 2006-001936-30, NCT00404092
|
|
7.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-004432-70, NCT00501098
|
|
8.
|
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 2 to 17
Sponsor: NCI
Protocol IDs: NCI-01-C-0084C, NCT00020527
|
Mobile | Español
